Buy this ASX 200 stock for an 11% gain and 4%+ dividend yield

Bell Potter is bullish about this stock. But why?

| More on:
Two smiling work colleagues discuss an investment or business plan at their office.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you are looking for a combination of market-beating gains and an attractive dividend yield, then it could be worth considering the ASX 200 stock in this article.

That's because analysts at Bell Potter believe this stock is undervalued at current levels and could deliver strong returns for investors over the next 12 months.

Which ASX 200 stock?

The stock in question is agribusiness company Elders Ltd (ASX: ELD).

Bell Potter notes that its shares have underperformed recently due to doubts over its ability to hit its guidance. The broker appears to believe this is unwarranted and that Elders can deliver on expectations. It said:

The ELD share price has stagnated following the release of the 1H24 results where FY24e EBIT guidance of $120-140m was reiterated, implying 2H24e EBIT of $82- 102m (vs. $88.0m in 2H23 and $38.5m 1H24). In aggregate we would see the combination of acquisitions, business investment and stronger YOY trends in livestock as generally supportive of our FY24e forecasts and the FY24e EBIT guidance range.

In light of this, its analysts have reaffirmed their buy rating and $9.30 price target on the ASX 200 stock this morning.

Based on the latest Elders share price of $8.36, this implies potential upside of 11.2% for investors between now and this time next year.

In addition, the broker is forecasting partially franked dividends of 36 cents per share in FY 2024 and then 41 cents per share in FY 2025. This equates to dividend yields of 4.3% and 4.9%, respectively, for investors.

So, if we imagine this means a 4.6% dividend yield over the next 12 months (the FY 2024 final dividend and FY 2025 interim dividend), the total potential return increases to 15.8% for investors.

If this proves accurate, a $10,000 investment into this ASX 200 stock today could turn into $11,580.

What else did the broker say?

Bell Potter highlights that Elders' shares are trading at an attractive discount to historical average multiples at a time when its earnings growth profile is starting to recover. It concludes:

Our Buy rating is unchanged. At a high level we see ELD trading at 7.7-7.9x ThroughThe-Cycle (TTC) EBITDA, which we estimate at $270-280m reflecting YTD business investment ($68m in 1H24 + $51m on Knight Frank TAS), a discount to its historical average of 8.5x. Improving livestock turnover, the benefits of recent business investment and a stabilisation in agricultural input prices in our view support a recovering earnings growth profile in 2H24e-1H25e.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Elders. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Two businesspeople walk together in an office, smiling as they enjoy a good business relationship.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A man sees some good news on his phone and gives a little cheer.
Broker Notes

These ASX shares could rise 20% and ~40%

Analysts think buyers of these shares could generate big returns over the next 12 months.

Read more »

Exhausted young Caucasian woman lying on comfortable sofa in living room sleeping after hard-working day, tired millennial female fall asleep on couch at home, take nap or daydream, fatigue concept
Healthcare Shares

ResMed shares are in a two-month lull. Is this a chance to buy?

ResMed shares are still trading below the price targets of several brokers.

Read more »

A female stockbroker reviews share price performance in her office with the city shown in the background through her windows
Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

Morgans names more of the best ASX stocks to buy in June

These ASX stocks are highly rated by analysts at Morgans in June.

Read more »

a man raises his fists to the air in joyous celebration while learning some exciting good news via his computer screen in an office setting.
Broker Notes

Guess which ASX 100 stock has 'high quality' earnings and could rise 22%

Goldman Sachs thinks big returns could be on the cards for buyers of this stock.

Read more »

Modern accountant woman in a light business suit in modern green office with documents and laptop.
Financial Shares

Beaten-up ASX 200 stock rebounds 15%. Macquarie says more to come

The sell-off could be unfounded, one broker says.

Read more »

Three people in a corporate office pour over a tablet, ready to invest.
Broker Notes

Morgans names the best ASX 200 stocks to buy in June

Morgans expects good returns from these top ASX 200 shares over the next 12 months.

Read more »